MAP2K6
Overview[edit | edit source]
MAP2K6 (Mitogen-Activated Protein Kinase Kinase 6), also known as MEK6, is a dual-specificity protein kinase that plays a critical role in the mitogen-activated protein kinase (MAPK) signaling pathway. This enzyme is encoded by the MAP2K6 gene in humans. MAP2K6 is involved in the regulation of various cellular processes, including cell proliferation, differentiation, and apoptosis.
Structure[edit | edit source]
MAP2K6 is a member of the MAP kinase kinase family, which is characterized by its ability to phosphorylate both threonine and tyrosine residues. The protein consists of a kinase domain that is responsible for its enzymatic activity. The structure of MAP2K6 allows it to interact with upstream activators and downstream targets, facilitating the transmission of signals within the cell.
Function[edit | edit source]
MAP2K6 is primarily involved in the p38 MAPK pathway, where it acts as an activator of the p38 MAPK. Upon activation by upstream kinases such as MAP kinase kinase kinases (MAP3Ks), MAP2K6 phosphorylates and activates p38 MAPK, which then goes on to phosphorylate various substrates involved in inflammatory responses, stress responses, and cell cycle regulation.
Clinical Significance[edit | edit source]
Dysregulation of MAP2K6 has been implicated in several diseases, including cancer, inflammatory disorders, and neurodegenerative diseases. Overexpression or constitutive activation of MAP2K6 can lead to aberrant cell signaling, contributing to tumorigenesis and cancer progression. Conversely, inhibition of MAP2K6 activity is being explored as a therapeutic strategy in conditions where its activity is pathologically increased.
Research[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms by which MAP2K6 regulates cellular processes and its role in disease. Studies are also exploring the development of specific inhibitors that target MAP2K6 for therapeutic purposes.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
